What diseases does eltrombopag treat
Eltrombopag is an oral thrombopoietin receptor agonist primarily used to treat specific types of thrombocytopenia, including chronic liver disease-related thrombocytopenia and chronic immune thrombocytopenia (ITP), by stimulating the proliferation and differentiation of bone marrow megakaryocytes to increase platelet count.
Chronic liver disease associated thrombocytopenia
(1) Preoperative treatment: Used for adult chronic liver disease patients planning to undergo dental or medical surgery to increase platelet count to safe levels and reduce intraoperative bleeding risk.
(2) Applicable standards: Suitable for patients with mild to moderate liver function impairment classified as Child Pugh A or B. Patients with severe liver function impairment should adjust the dosage carefully.
Chronic immune thrombocytopenia (ITP)
(1) Adult patients: Suitable for adult ITP patients who have poor response to first-line treatments such as cortisol and immunoglobulin, as a second-line treatment plan.
(2) Pediatric patients: can be used to treat chronic or persistent ITP in pediatric patients, but safety and efficacy must be rigorously evaluated.
3 Other potential indications
(1) Aplastic anemia: Some studies have shown that it may be effective for certain patients with acquired aplastic anemia, but it has not yet become a standard indication.
(2) Chemotherapy induced thrombocytopenia: Currently, evidence is limited and further clinical trials are needed to validate its efficacy and safety in such patients.
Disclaimer：《What diseases does eltrombopag treat》Edited and sorted by Seagull Pharmacy's editors. Please contact us in time if there is any infringement. In addition, the suggestions for drug usage, dosage and disease mentioned in the article are only for medical staff's reference, and can not be used as any basis for medication！